Summary
Fibrinogen factor I is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as fibrin glue or fibrin sealant, the majority of available formulations contain a mixture of pooled plasmaderived fibrinogen and the enzyme thrombin.
Market Segment as follows:
By Region
AsiaPacific
North America
Europe
South America
Middle East Africa
By Type
Human Fibrinogen Concentrate
Animal?Fibrinogen Concentrate
By Application
Congenital Fibrinogen Deficiency
Surgical Procedures Trauma Patients, Cardiovascular Surgery Patients, PPH Patients, Plastic Surgery Patients
By Company
CSL Behring
Baxter
Johnson Johnson Ethicon
LFB Group
ProFibrix BV The Medicines Company
Shanghai RAAS
Jiangxi Boya BioPharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
The main contents of the report including:
Section 1:
Product definition, type and application, global and regional market overview;
Section 2:
Global and regional Market competition by company;
Section 3:
Global and regional sales revenue, volume and price by type;
Section 4:
Global and regional sales revenue, volume and price by application;
Section 5:
Regional export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Original Article: Global and Regional Fibrinogen Concentrate Market Research Report 2017 [Report Updated: 18102017] Prices from USD $3500
NEXT ARTICLE